Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202

BACKGROUND: In prostate cancer, end points that reliably portend prognosis and treatment benefit (surrogate end points) can accelerate therapy development. Although surrogate end point candidates have been evaluated in the context of radiotherapy and short-term androgen deprivation (AD), potential s...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Oncol
Prif Awduron: Dignam, James J., Hamstra, Daniel A., Lepor, Herbert, Grignon, David, Brereton, Harmar, Currey, Adam, Rosenthal, Seth, Zeitzer, Kenneth L., Venkatesan, Varagur M., Horwitz, Eric M., Pisansky, Thomas M., Sandler, Howard M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society of Clinical Oncology 2019
Pynciau:
ORIGINAL REPORTS
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6338393/
https://ncbi.nlm.nih.gov/pubmed/30526194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00154
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg